Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 4 5Phase 3 5Phase 2 5Phase 1 3Phase 2/3 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Head & Neck 1

Conditions

Paclitaxel-induced Neuropathy 1Mesothelioma 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Magnesium Sulfate × Clear all
NCT04481672 2022-01-11

Intravenous Magnesium in Patients Receiving Cisplatin

Dana-Farber Cancer Institute

Phase 1 Completed
5 enrolled
Other solid neoplasmThoracic

Mesothelioma

NCT01804205 2018-03-14

Magnesium Sulphate and Rocuronium in Patients Over 60

Instituto Nacional de Cancer, Brazil

Phase 1 Completed
64 enrolled
Head & Neck

Head and Neck Neoplasms

NCT01682499 2014-09-25

Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy

Beth Israel Medical Center

Phase 1 Completed
50 enrolled

Paclitaxel-induced Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡